Full Press Release Details
Bacterin CEO Dan Goldberger to be Guest
on Fox Business Network's After the Bell with Liz Claman
BELGRADE, Mont., November 11, 2014 (GLOBE NEWSWIRE) -- Bacterin
International Holdings, Inc. (NYSE:BONE) today announced its CEO Dan Goldberger will be a guest on FOX Business Network's After
the Bell with Liz Claman at approximately 4:15 PM/ET on Tuesday, November 11, 2014. Bacterin is a medical device company and accredited
tissue bank that designs, processes, manufactures, and markets advanced medical products.
During the show, Mr.Goldberger is expected to talk about the
company's growth opportunities in regenerative medicine, specifically as they apply to human bone, tendons and skin and the importance
of Bacterin's Circle of Life efforts with respect to tissue donation.
Mr.Goldberger, who has been CEO of Bacterin since August 2013,
has more than 25 years of experience in the medical technology and device industry. During his career, he has held several executive
leadership positions within the industry. He holds a BS in Mechanical Engineering from the Massachusetts Institute of Technology
and an MS in Mechanical Engineering from Stanford University. Goldberger is a named inventor on more than 60 U.S. patents.
About Bacterin International Holdings
Bacterin International Holdings, Inc. (NYSE:BONE) develops,
manufactures and markets biologics products to domestic and international markets. These products are used in a variety of applications
including enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion
of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries.
Bacterin's Medical Device division develops, employs, and licenses
coatings for various medical device applications. For further information, please visit www.bacterin.com.
Important Cautions Regarding Forward-looking Statements
news release and the referenced presentation contain certain disclosures that may be deemed forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995 that are subject to significant risks and uncertainties. Forward-looking
statements include statements that are predictive in nature, that depend upon or refer to future events or conditions, or that
include words such as "continue," "efforts," "expects," "anticipates," "intends,"
"plans," "believes," "estimates," "projects," "forecasts," "strategy,"
"will," "goal," "target," "prospects," "potential," "optimistic," "confident,"
"likely," "probable" or similar expressions or the negative thereof. Statements of historical fact also may
be deemed to be forward-looking statements. We caution that these statements by their nature involve risks and uncertainties, and
actual results may differ materially depending on a variety of important factors, including, among others: the Company's ability
to meet its existing and anticipated contractual obligations, including financial covenant and other obligations contained in the
Company's secured lending facility; the Company's
ability to manage cash flow and achieve profitability; the Company's
ability to remain listed on the NYSE MKT; the Company's ability to develop, market, sell and distribute desirable applications,
products and services and to protect its intellectual property; the ability of the Company's sales force to achieve expected results;
the ability of the Company's customers to pay and the timeliness of such payments; the Company's ability to obtain financing as
and when needed; changes in consumer demands and preferences; the Company's ability to attract and retain management and employees
with appropriate skills and expertise; the Company's ability
to successfully conclude government investigations; the impact of changes in market, legal and regulatory conditions and in the
applicable business environment, including actions of competitors; and other factors. Additional risk factors are listed in the
Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q under the heading "Risk Factors." The Company
undertakes no obligation to release publicly any revisions to any forward-looking statements to reflect events or circumstances
after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.